
Shingles vaccine tied to lower dementia risk, with newer shots showing stronger signals
Natural-experiment studies across Wales, Australia, Canada, and the US consistently link shingles vaccination with reduced dementia risk, and newer data suggest that Shingrix may offer larger protective benefits than the older Zostavax—potentially by lowering brain inflammation from varicella-zoster reactivation—though causality and gender differences require further study.













